Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin Springer Verlag
    • Subject Terms:
    • Abstract:
      Aims/hypothesis: The prevalence of diabetes and heart failure is increasing, and diabetes has been associated with an increased risk of heart failure. However, whether diabetes confers the same excess risk of heart failure in women and men is unknown. The aim of this study was to conduct a comprehensive systematic review with meta-analysis of possible sex differences in the excess risk of heart failure consequent to diabetes. Our null hypothesis was that there is no such sex difference.
      Methods: A systematic search was conducted in PubMed for population-based cohort studies published between January 1966 and November 2018. Studies were selected if they reported sex-specific estimates of RRs for heart failure associated with diabetes, and its associated variability, which were adjusted at least for age. Random-effects meta-analyses with inverse variance weighting were used to obtain pooled sex-specific RRs and women-to-men ratio of RRs (RRRs) for heart failure associated with diabetes.
      Results: Data from 47 cohorts, involving 12,142,998 individuals and 253,260 heart failure events, were included. The pooled multiple-adjusted RR for heart failure associated with type 1 diabetes was 5.15 (95% CI 3.43, 7.74) in women and 3.47 (2.57, 4.69) in men, leading to an RRR of 1.47 (1.44, 1.90). Corresponding pooled RRs for heart failure associated with type 2 diabetes were 1.95 (1.70, 2.22) in women and 1.74 (1.55, 1.95) in men, with a pooled RRR of 1.09 (1.05, 1.13).
      Conclusions/interpretation: The excess risk of heart failure associated with diabetes is significantly greater in women with diabetes than in men with diabetes. PROSPERO registration: CRD42019135246.
    • References:
      J Diabetes Complications. 2017 Jan;31(1):74-79. (PMID: 27746087)
      Diabetes Care. 2008 Jul;31(7):1389-91. (PMID: 18375411)
      Diabetes Obes Metab. 2019 Jan;21(1):112-119. (PMID: 30091215)
      Diabetologia. 2018 Oct;61(10):2140-2154. (PMID: 30027404)
      Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1081-1091. (PMID: 30318112)
      JAMA. 1995 Oct 4;274(13):1037-42. (PMID: 7563454)
      Int J Endocrinol. 2017;2017:6039356. (PMID: 28316624)
      Circ Heart Fail. 2010 Nov;3(6):698-705. (PMID: 20798277)
      Atherosclerosis. 2008 Jun;198(2):396-402. (PMID: 18093594)
      Diabetes Care. 2016 Nov;39(11):1987-1995. (PMID: 27493134)
      J Card Fail. 2009 Mar;15(2):152-7. (PMID: 19254675)
      Arch Intern Med. 2001 Apr 9;161(7):996-1002. (PMID: 11295963)
      Circulation. 2018 Dec 11;138(24):2774-2786. (PMID: 29950404)
      Circulation. 2015 Dec 22;132(25):2424-47. (PMID: 26644329)
      Circulation. 2007 Jun 26;115(25):3213-23. (PMID: 17592090)
      J Pediatr. 2009 Nov;155(5):668-72.e1-3. (PMID: 19643434)
      Diabetologia. 2018 Nov;61(11):2300-2309. (PMID: 30094466)
      Lancet Diabetes Endocrinol. 2015 Nov;3(11):876-85. (PMID: 26388415)
      J Womens Health (Larchmt). 2005 Jun;14(5):418-23. (PMID: 15989414)
      JACC Heart Fail. 2016 Dec;4(12):911-919. (PMID: 27908389)
      Lancet Diabetes Endocrinol. 2015 Feb;3(2):105-13. (PMID: 25466521)
      BMC Cardiovasc Disord. 2014 May 03;14:61. (PMID: 24884382)
      J Intern Med. 2013 Aug;274(2):176-91. (PMID: 23565931)
      Stroke. 2013 Sep;44(9):2394-401. (PMID: 23821229)
      Eur J Heart Fail. 2018 May;20(5):853-872. (PMID: 29520964)
      Diabetes Care. 1998 Aug;21(8):1258-65. (PMID: 9702430)
      Diabetologia. 2012 Jan;55(1):80-7. (PMID: 21861177)
      Lancet Diabetes Endocrinol. 2015 Mar;3(3):198-206. (PMID: 25660575)
      JAMA. 2000 Apr 19;283(15):2008-12. (PMID: 10789670)
      Diabetes Care. 2016 Feb;39(2):300-7. (PMID: 26681727)
      Diabetes Care. 2005 Mar;28(3):514-20. (PMID: 15735180)
      Lancet. 2014 Jun 7;383(9933):1973-80. (PMID: 24613026)
      Lancet Diabetes Endocrinol. 2018 Aug;6(8):603. (PMID: 30053987)
      Eur Heart J. 2013 Oct;34(39):3035-87. (PMID: 23996285)
      Aust N Z J Public Health. 2010 Jun;34(3):311-4. (PMID: 20618275)
      Eur J Heart Fail. 2014 Apr;16(4):409-18. (PMID: 24464683)
      Diabetes Care. 2017 May;40(5):671-678. (PMID: 28255009)
      Endocrine. 2017 Jan;55(1):66-76. (PMID: 27477292)
      Scand J Prim Health Care. 2004 Mar;22(1):27-31. (PMID: 15119517)
      J Diabetes Complications. 2014 May-Jun;28(3):316-22. (PMID: 24461547)
      Diabetes Care. 2018 Apr;41(4):731-738. (PMID: 29317451)
      Lancet Diabetes Endocrinol. 2015 Jun;3(6):437-449. (PMID: 25960160)
      Gend Med. 2010 Dec;7(6):593-9. (PMID: 21195359)
      Diabetologia. 2014 Aug;57(8):1542-51. (PMID: 24859435)
    • Grant Information:
      MR/P014550/1 United Kingdom MRC_ Medical Research Council
    • Contributed Indexing:
      Keywords: Diabetes; Heart failure; Meta-analysis; Sex differences; Systematic review
    • Publication Date:
      Date Created: 20190719 Date Completed: 20200413 Latest Revision: 20240719
    • Publication Date:
      20240719
    • Accession Number:
      PMC6677875
    • Accession Number:
      10.1007/s00125-019-4926-x
    • Accession Number:
      31317230